BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Smith V, Scirè CA, Talarico R, Airo P, Alexander T, Allanore Y, Bruni C, Codullo V, Dalm V, De Vries-Bouwstra J, Della Rossa A, Distler O, Galetti I, Launay D, Lepri G, Mathian A, Mouthon L, Ruaro B, Sulli A, Tincani A, Vandecasteele E, Vanhaecke A, Vanthuyne M, Van den Hoogen F, Van Vollenhoven R, Voskuyl AE, Zanatta E, Bombardieri S, Burmester G, Eurico FJ, Frank C, Hachulla E, Houssiau F, Mueller-Ladner U, Schneider M, van Laar JM, Vieira A, Cutolo M, Mosca M, Matucci-Cerinic M. Systemic sclerosis: state of the art on clinical practice guidelines. RMD Open 2018;4:e000782. [PMID: 30402270 DOI: 10.1136/rmdopen-2018-000782] [Cited by in Crossref: 38] [Cited by in F6Publishing: 51] [Article Influence: 9.5] [Reference Citation Analysis]
Number Citing Articles
1 Cottin V, Martinez FJ, Smith V, Walsh SL. Multidisciplinary teams in the clinical care of fibrotic interstitial lung disease: current perspectives. Eur Respir Rev 2022;31:220003. [DOI: 10.1183/16000617.0003-2022] [Reference Citation Analysis]
2 Ebata S, Yoshizaki-Ogawa A, Sato S, Yoshizaki A. New Era in Systemic Sclerosis Treatment: Recently Approved Therapeutics. J Clin Med 2022;11:4631. [PMID: 35956246 DOI: 10.3390/jcm11154631] [Reference Citation Analysis]
3 Cheng H, Yu Z, Yan C, Yang H, Gao C, Wen H. Long-Term Efficacy and Low Adverse Events of Methylprednisolone Pulses Combined to Low-Dose Glucocorticoids for Systemic Sclerosis: A Retrospective Clinical Study of 10 Years’ Follow-Up. JIR 2022;Volume 15:4421-33. [DOI: 10.2147/jir.s373387] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 RuizdelRio J, Muñoz P, Carreira P, Maestro D, Pablos JL, Palanca A, Merino J, Serrano-Mollar A, Merino R, Tamayo E, Lopez-Hoyos M, Diaz-Gonzalez F, Martinez-Taboada V, Villar AV. Profibrotic Role of Inducible Heat Shock Protein 90α Isoform in Systemic Sclerosis. J Immunol 2022;209:38-48. [PMID: 35715007 DOI: 10.4049/jimmunol.2100430] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Ruaro B, Salton F, Baratella E, Confalonieri P, Geri P, Pozzan R, Torregiani C, Bulla R, Confalonieri M, Matucci-cerinic M, Hughes M. An Overview of Different Techniques for Improving the Treatment of Pulmonary Hypertension Secondary in Systemic Sclerosis Patients. Diagnostics 2022;12:616. [DOI: 10.3390/diagnostics12030616] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
6 Ruaro B, Baratella E, Confalonieri P, Confalonieri M, Vassallo FG, Wade B, Geri P, Pozzan R, Caforio G, Marrocchio C, Cova MA, Salton F. High-Resolution Computed Tomography and Lung Ultrasound in Patients with Systemic Sclerosis: Which One to Choose? Diagnostics (Basel) 2021;11:2293. [PMID: 34943531 DOI: 10.3390/diagnostics11122293] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
7 Burlui AM, Cardoneanu A, Macovei LA, Rezus C, Boiculese LV, Graur M, Rezus E. Diet in Scleroderma: Is There a Need for Intervention? Diagnostics (Basel) 2021;11:2118. [PMID: 34829464 DOI: 10.3390/diagnostics11112118] [Reference Citation Analysis]
8 Galetti I. Living with systemic sclerosis: the point of view of patients. Curr Med Res Opin 2021;37:1-4. [PMID: 34726111 DOI: 10.1080/03007995.2021.1992369] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Ruaro B, Bruni C, Wade B, Baratella E, Confalonieri P, Antonaglia C, Geri P, Biolo M, Confalonieri M, Salton F. Laser Speckle Contrast Analysis: Functional Evaluation of Microvascular Damage in Connective Tissue Diseases. Is There Evidence of Correlations With Organ Involvement, Such as Pulmonary Damage? Front Physiol 2021;12:710298. [PMID: 34707506 DOI: 10.3389/fphys.2021.710298] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
10 Ruaro B, Baratella E, Confalonieri P, Wade B, Marrocchio C, Geri P, Busca A, Pozzan R, Andrisano AG, Cova MA, Confalonieri M, Salton F. High-Resolution Computed Tomography: Lights and Shadows in Improving Care for SSc-ILD Patients. Diagnostics (Basel) 2021;11:1960. [PMID: 34829307 DOI: 10.3390/diagnostics11111960] [Cited by in Crossref: 1] [Cited by in F6Publishing: 10] [Article Influence: 1.0] [Reference Citation Analysis]
11 Santiago T, Santos E, Duarte AC, Martins P, Sousa M, Guimarães F, Azevedo S, Ferreira RM, Guerra M, Cordeiro A, Cordeiro I, Pimenta S, Pinto P, Pinto AM, Salvador MJ, Silva JAPD. Happiness, quality of life and their determinants among people with systemic sclerosis: a structural equation modelling approach. Rheumatology (Oxford) 2021;60:4717-27. [PMID: 33521812 DOI: 10.1093/rheumatology/keab083] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
12 Gieszczyk-Strózik K, Wybraniec MT, Widuchowska M, Brzezińska-Wcisło L, Kotyla P, Kucharz E, Mizia-Stec K. CHLD score, a new score based on traditional risk factor evaluation and long-term cardiovascular outcomes in patients with systemic sclerosis. Sci Rep 2021;11:19598. [PMID: 34599271 DOI: 10.1038/s41598-021-99215-x] [Reference Citation Analysis]
13 Kaymaz S, Halil Y, Kaya H, Karasu U, Cobankara V. The relationship of ocular parameters with clinical parameters and disease-related quality of life in patients with systemic sclerosis: A cross-sectional study. Int J Rheum Dis 2021;24:1308-16. [PMID: 34506073 DOI: 10.1111/1756-185X.14216] [Reference Citation Analysis]
14 Kocher A, Simon M, Dwyer AA, Blatter C, Bogdanovic J, Künzler-Heule P, Villiger PM, Dan D, Distler O, Walker UA, Nicca D. Patient and healthcare professional eHealth literacy and needs for systemic sclerosis support: a mixed methods study. RMD Open 2021;7:e001783. [PMID: 34475248 DOI: 10.1136/rmdopen-2021-001783] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
15 Caetano J, Batista F, Amaral MC, Oliveira S, Alves JD. Acute hospitalization in a cohort of patients with systemic sclerosis: a 10-year retrospective cohort study. Rheumatol Int 2021. [PMID: 34480254 DOI: 10.1007/s00296-021-04983-4] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
16 Talarico R, Marinello D, Bombardieri S, Burmester G, Fonseca J, Frank C, Galetti I, Hachulla E, Houssiau F, Mueller-Ladner U, Schneider M, Smith V, Turchetti G, van Laar JM, Vieira A, Cutolo M, Mosca M. Clinical practice guidelines adherence, knowledge and awareness in rare and complex connective tissue diseases across Europe: results from the first ERN ReCONNET survey. RMD Open 2020;6:0. [PMID: 32868449 DOI: 10.1136/rmdopen-2020-001344] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
17 Vandecasteele E, Melsens K, Vanhaecke A, Blockmans D, Bonroy C, Carton C, Deschepper E, De Keyser F, Houssiau F, Piette Y, Vanthuyne M, Verbeke K, Westhovens R, Wuyts WA, De Langhe E, Brusselle G, Smith V. Incidence, prevalence and long-term progression of Goh algorithm rated interstitial lung disease in systemic sclerosis in two independent cohorts in flanders: A retrospective cohort study. Semin Arthritis Rheum 2021;51:969-76. [PMID: 34403812 DOI: 10.1016/j.semarthrit.2021.07.018] [Reference Citation Analysis]
18 Ritschl V, Ferreira RJO, Santos EJF, Fernandes R, Juutila E, Mosor E, Santos-Costa P, Fligelstone K, Schraven L, Stummvoll G, Salvador M, Poole JL, van den Ende C, Boström C, Stamm TA. Suitability for e-health of non-pharmacological interventions in connective tissue diseases: scoping review with a descriptive analysis. RMD Open 2021;7:e001710. [PMID: 34326205 DOI: 10.1136/rmdopen-2021-001710] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
19 Voulgaris TA, Karamanolis GP. Esophageal manifestation in patients with scleroderma. World J Clin Cases 2021; 9(20): 5408-5419 [PMID: 34307594 DOI: 10.12998/wjcc.v9.i20.5408] [Reference Citation Analysis]
20 Chuealee W, Foocharoen C, Mahakkanukrauh A, Suwannaroj S, Pongchaiyakul C, Nanagara R. Prevalence and predictive factors of osteoporosis in Thai systemic sclerosis. Sci Rep 2021;11:9424. [PMID: 33941800 DOI: 10.1038/s41598-021-88792-6] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
21 Ruaro B, Santiago T, Hughes M, Lepri G, Poillucci G, Baratella E, Salton F, Confalonieri M. The Updated Role of Ultrasound in Assessing Dermatological Manifestations in Systemic Sclerosis. Open Access Rheumatol 2021;13:79-91. [PMID: 33953621 DOI: 10.2147/OARRR.S282612] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
22 Ruaro B, Confalonieri M, Salton F, Wade B, Baratella E, Geri P, Confalonieri P, Kodric M, Biolo M, Bruni C. The Relationship between Pulmonary Damage and Peripheral Vascular Manifestations in Systemic Sclerosis Patients. Pharmaceuticals (Basel) 2021;14:403. [PMID: 33922710 DOI: 10.3390/ph14050403] [Cited by in Crossref: 2] [Cited by in F6Publishing: 11] [Article Influence: 2.0] [Reference Citation Analysis]
23 Spierings J, van Rhenen A, Welsing PM, Marijnissen AC, De Langhe E, Del Papa N, Dierickx D, Gheorghe KR, Henes J, Hesselstrand R, Kerre T, Ljungman P, van de Loosdrecht AA, Marijt EW, Mayer M, Schmalzing M, Schroers R, Smith V, Voll RE, Vonk MC, Voskuyl AE, de Vries-Bouwstra JK, Walker UA, Wuttge DM, van Laar JM. A randomised, open-label trial to assess the optimal treatment strategy in early diffuse cutaneous systemic sclerosis: the UPSIDE study protocol. BMJ Open 2021;11:e044483. [PMID: 33737437 DOI: 10.1136/bmjopen-2020-044483] [Cited by in Crossref: 1] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
24 Bruni C, Ross L. Cardiac involvement in systemic sclerosis: Getting to the heart of the matter. Best Pract Res Clin Rheumatol 2021;35:101668. [PMID: 33736950 DOI: 10.1016/j.berh.2021.101668] [Cited by in Crossref: 2] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
25 Arase M, Kusunose K, Morita S, Yamaguchi N, Hirata Y, Nishio S, Okushi Y, Ise T, Tobiume T, Yamaguchi K, Fukuda D, Yagi S, Yamada H, Soeki T, Wakatsuki T, Sata M. Cardiac reserve by 6-minute walk stress echocardiography in systemic sclerosis. Open Heart 2021;8:e001559. [PMID: 33608475 DOI: 10.1136/openhrt-2020-001559] [Reference Citation Analysis]
26 Hoffmann-Vold AM, Bendstrup E, Dimitroulas T, Hesselstrand R, Morais A, Peltomaa R, Smith V, Welling J, Vonk MC, Wuyts WA. Identifying unmet needs in SSc-ILD by semi-qualitative in-depth interviews. Rheumatology (Oxford) 2021:keab154. [PMID: 33587103 DOI: 10.1093/rheumatology/keab154] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
27 Bruni C, Cometi L, Gigante A, Rosato E, Matucci-Cerinic M. Prediction and primary prevention of major vascular complications in systemic sclerosis. Eur J Intern Med 2021;87:51-8. [PMID: 33551291 DOI: 10.1016/j.ejim.2021.01.022] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
28 Vanhaecke A, De Schepper S, Paolino S, Heeman L, Callens H, Gutermuth J, Nguyen S, Cutolo M, Smith V. Coexistence of systemic and localized scleroderma: a systematic literature review and observational cohort study. Rheumatology (Oxford) 2020;59:2725-33. [PMID: 32653905 DOI: 10.1093/rheumatology/keaa297] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
29 Roennow A, Sauvé M, Welling J, Riggs RJ, Kennedy AT, Galetti I, Brown E, Leite C, Gonzalez A, Portales Guiraud AP, Houÿez F, Camp R, Gilbert A, Gahlemann M, Moros L, Luna Flores JL, Schmidt F, Sauter W, Finnern H. Collaboration between patient organisations and a clinical research sponsor in a rare disease condition: learnings from a community advisory board and best practice for future collaborations. BMJ Open 2020;10:e039473. [PMID: 33328257 DOI: 10.1136/bmjopen-2020-039473] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
30 Ruaro B, Casabella A, Molfetta L, Salton F, Confalonieri P, Confalonieri M, Baratella E, De Tanti A, Bruni C. What Role Does Trabecular Bone Score Play in Chronic Inflammatory Rheumatic Diseases? Front Med (Lausanne) 2020;7:600697. [PMID: 33425947 DOI: 10.3389/fmed.2020.600697] [Cited by in Crossref: 1] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
31 Abdouh I, Porter S, Fedele S, Elgendy N, Ni Riordain R. Web-based information on the treatment of the mouth in systemic sclerosis. BMC Rheumatol 2020;4:61. [PMID: 33292857 DOI: 10.1186/s41927-020-00160-5] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
32 Yang C, Tang S, Zhu D, Ding Y, Qiao J. Classical Disease-Specific Autoantibodies in Systemic Sclerosis: Clinical Features, Gene Susceptibility, and Disease Stratification. Front Med (Lausanne) 2020;7:587773. [PMID: 33330547 DOI: 10.3389/fmed.2020.587773] [Cited by in Crossref: 1] [Cited by in F6Publishing: 8] [Article Influence: 0.5] [Reference Citation Analysis]
33 Gargani L, Bruni C, De Marchi D, Romei C, Guiducci S, Bellando-Randone S, Aquaro GD, Pepe A, Neri E, Colagrande S, Falaschi F, Moggi-Pignone A, Pingitore A, Matucci-Cerinic M. Lung magnetic resonance imaging in systemic sclerosis: a new promising approach to evaluate pulmonary involvement and progression. Clin Rheumatol 2021;40:1903-12. [PMID: 33161470 DOI: 10.1007/s10067-020-05491-9] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
34 Benvenuti F, Zanatta E, Avouac J, Müller-ladner U, Cozzi F, Hoffmann-vold A, Gabrielli A, Distler O, Matucci-cerinic M, Allanore Y, Doria A. The power of the EUSTAR cohort: key findings to date and implications for management of systemic sclerosis patients. Expert Review of Clinical Immunology 2020;16:1065-74. [DOI: 10.1080/1744666x.2021.1836962] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
35 Liakouli V, Ciaffi J, Ursini F, Ruscitti P, Meliconi R, Ciccia F, Cipriani P, Giacomelli R. Efficacy and safety of imatinib mesylate in systemic sclerosis. A systematic review and meta-analysis. Expert Rev Clin Immunol 2020;16:931-42. [PMID: 32893688 DOI: 10.1080/1744666X.2020.1813569] [Reference Citation Analysis]
36 Pacini G, Paolino S, C Trombetta A, Goegan F, Pizzorni C, Alessandri E, Patanè M, Gotelli E, Ferrari G, Cattelan F, Ghio M, Casabella A, Smith V, Cutolo M. Lower urinary tract symptoms in systemic sclerosis: a detailed investigation. Rheumatology (Oxford) 2020;59:1315-24. [PMID: 31586421 DOI: 10.1093/rheumatology/kez438] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
37 Stöcker JK, Vonk MC, van den Hoogen FHJ, Nijhuis-van der Sanden MWG, Spierings J, Staal JB, Satink T, van den Ende CHM; ARCH study group. Room for improvement in non-pharmacological systemic sclerosis care? - a cross-sectional online survey of 650 patients. BMC Rheumatol 2020;4:43. [PMID: 32760879 DOI: 10.1186/s41927-020-00142-7] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
38 Ruaro B, Nallino MG, Casabella A, Salton F, Confalonieri P, De Tanti A, Bruni C. Monitoring the microcirculation in the diagnosis and follow-up of systemic sclerosis patients: Focus on pulmonary and peripheral vascular manifestations. Microcirculation 2020;27:e12647. [PMID: 32603500 DOI: 10.1111/micc.12647] [Cited by in Crossref: 8] [Cited by in F6Publishing: 12] [Article Influence: 4.0] [Reference Citation Analysis]
39 Zhang S, Lv J, Ren X, Hao X, Zhou P, Wang Y. The efficacy and safety of fecal microbiota transplantation in the treatment of systemic sclerosis: A protocol for systematic review and meta analysis. Medicine (Baltimore) 2020;99:e21267. [PMID: 32664182 DOI: 10.1097/MD.0000000000021267] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
40 Condon SE, Roesch SC, Clements PJ, Furst DE, Weisman MH, Malcarne VL. Coping profiles and health outcomes among individuals with systemic sclerosis: A latent profile analysis approach. Journal of Scleroderma and Related Disorders 2020;5:231-6. [DOI: 10.1177/2397198320930138] [Reference Citation Analysis]
41 Ratanawatkul P, Solomon JJ, Kim D, George MP, Matarrese McGibbon LR, Demoruelle MK, Maleki-Fischbach M, Amigues I, Kastsianok L, Fernández Pérez ER. Trends in systemic sclerosis and systemic sclerosis-related pulmonary arterial hypertension mortality in the USA. ERJ Open Res 2020;6:00309-2019. [PMID: 32577417 DOI: 10.1183/23120541.00309-2019] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
42 Paolino S, Pacini G, Schenone C, Patanè M, Sulli A, Sukkar SG, Lercara A, Pizzorni C, Gotelli E, Cattelan F, Goegan F, Smith V, Cutolo M. Nutritional Status and Bone Microarchitecture in a Cohort of Systemic Sclerosis Patients. Nutrients 2020;12:E1632. [PMID: 32492873 DOI: 10.3390/nu12061632] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
43 Hughes M, Alcacer-pitarch B, Allanore Y, Baron M, Boin F, Bruni C, Chung L, Del Galdo F, Denton CP, Matucci-cerinic M. Digital ulcers: should debridement be a standard of care in systemic sclerosis? The Lancet Rheumatology 2020;2:e302-7. [DOI: 10.1016/s2665-9913(19)30164-x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
44 Devgire V, Martin AF, McKenzie L, Sandler RD, Hughes M. A systematic review of internet-based information for individuals with Raynaud's phenomenon and patients with systemic sclerosis. Clin Rheumatol 2020;39:2363-7. [PMID: 32152916 DOI: 10.1007/s10067-020-05023-5] [Cited by in Crossref: 7] [Cited by in F6Publishing: 10] [Article Influence: 3.5] [Reference Citation Analysis]
45 Kania G, Rudnik M, Distler O. Involvement of the myeloid cell compartment in fibrogenesis and systemic sclerosis. Nat Rev Rheumatol 2019;15:288-302. [PMID: 30953037 DOI: 10.1038/s41584-019-0212-z] [Cited by in Crossref: 17] [Cited by in F6Publishing: 25] [Article Influence: 8.5] [Reference Citation Analysis]
46 Wojteczek A, Dardzińska JA, Małgorzewicz S, Gruszecka A, Zdrojewski Z. Prevalence of malnutrition in systemic sclerosis patients assessed by different diagnostic tools. Clin Rheumatol 2020;39:227-32. [DOI: 10.1007/s10067-019-04810-z] [Cited by in Crossref: 14] [Cited by in F6Publishing: 18] [Article Influence: 4.7] [Reference Citation Analysis]
47 Snowden JA, Badoglio M, Alexander T. The rise of autologous HCT for autoimmune diseases: what is behind it and what does it mean for the future of treatment? An update on behalf of the EBMT Autoimmune Diseases Working Party. Expert Rev Clin Immunol 2019;15:981-5. [PMID: 31414932 DOI: 10.1080/1744666X.2019.1656526] [Cited by in Crossref: 8] [Cited by in F6Publishing: 13] [Article Influence: 2.7] [Reference Citation Analysis]
48 Smith V, Distler O, Cutolo M. Might Nailfold Capillaroscopy Be a “Proxy” for Lung Involvement in Connective Tissue Diseases? J Rheumatol 2019;46:1061-3. [DOI: 10.3899/jrheum.181408] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.7] [Reference Citation Analysis]
49 Cutolo M, Soldano S, Smith V. Pathophysiology of systemic sclerosis: current understanding and new insights. Expert Rev Clin Immunol. 2019;15:753-764. [PMID: 31046487 DOI: 10.1080/1744666x.2019.1614915] [Cited by in Crossref: 51] [Cited by in F6Publishing: 76] [Article Influence: 17.0] [Reference Citation Analysis]
50 Ruaro B, Smith V, Sulli A, Pizzorni C, Tardito S, Patané M, Paolino S, Cutolo M. Innovations in the Assessment of Primary and Secondary Raynaud's Phenomenon. Front Pharmacol 2019;10:360. [PMID: 31073287 DOI: 10.3389/fphar.2019.00360] [Cited by in Crossref: 13] [Cited by in F6Publishing: 19] [Article Influence: 4.3] [Reference Citation Analysis]
51 Kreps EO, Carton C, Cutolo M, Cutolo CA, Vanhaecke A, Leroy BP, Smith V. Ocular involvement in systemic sclerosis: A systematic literature review, it's not all scleroderma that meets the eye. Semin Arthritis Rheum 2019;49:119-25. [PMID: 30660382 DOI: 10.1016/j.semarthrit.2018.12.007] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 2.8] [Reference Citation Analysis]